Podcasts

OncLive On Air^® is a podcast from OncLive^® that provides oncology professionals with the resources and information they need to provide the best patient care. Segments cover every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. New episodes with exclusive interviews with leading oncology experts are released on Mondays and Thursdays.

OncClub

Heinz-Josef Lenz, MD, FACP, about the prognostic and predictive value of HER2 gene expression for patients with KRAS wild-type metastatic colorectal cancer (mCRC). Lenz is a professor in the Department of Medicine and the Department of Preventive Medicine in the Division of Oncology at the University of Southern California (USC) Keck School of Medicine in Los Angeles. He also serves as the associate director of Clinical Research, chair of the Gastrointestinal Oncology Program, and co-director of the Colorectal Center at the USC Norris Comprehensive Cancer Center

Amin Nassar, MD, hematology/oncology fellow, Yale University; Elias Bou Farhat, MD, postdoctoral research fellow, Department of Medicine, Brigham and Women’s Hospital

Michael Feigin, PhD

Jennifer M. King, MD

Pediatrics

Stephen Gottschalk, MD; Giedre Krenciute, PhD

Matthew Ehrhardt, MD, MS

Jordan B. Milner, MD; Mansi Dalal, MD; John Ligon, MD

Allison C. Rosenthal, DO

How This Is Building Me

D. Ross Camidge, MD, PhD; Kristie L. Kahl, MS, vice president, Content, MJH Life Sciences

D. Ross Camidge, MD, PhD; Jeff White, director, Public Relations and Strategic Communications, American Society for Radiation Oncology

D. Ross Camidge, MD, PhD; Chaplain Rhonda Cooper, primary chaplain, Johns Hopkins Sidney Kimmel Cancer Center

D. Ross Camidge, MD, PhD; Jashodeep Datta, MD, assistant professor, surgery, co-leader, Gastrointestinal Site Disease Group, University of Miami Sylvester Comprehensive Cancer Center, associate director, Translational Research, the Sylvester Pancreatic Cancer Research Institute

D. Ross Camidge, MD, PhD; İlker Arslan, MD, United States medical head, TDR Lung, AstraZeneca

D. Ross Camidge, MD, PhD; Chunxia Su, MD, PhD, professor, oncology, Tongji University School of Medicine, deputy director, Medical Oncology, Shanghai Pulmonary Hospital

Marvels in Medicine

FDA Approval Insights

Mikkael A. Sekeres, MD, professor, medicine, chief, Division of Hematology, Leukemia Section, University of Miami Sylvester Comprehensive Cancer Center

Saad Z. Usmani, MD, MBA, FACP, FASCO, hematologist-oncologist, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center

Elias Jabbour, MD, professor, medicine, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Zev A. Wainberg, MD, professor, medicine, the University of California, Los Angeles (UCLA), codirector, the UCLA Gastrointestinal Oncology Program

Matthew Galsky, MD

Matthew S. Davids, MD, MMSc

Two Onc Docs

Samantha A. Armstrong, MD, hematologist/oncologist, assistant professor, clinical medicine, Indiana University Health; Karine Tawagi, MD, hematologist/oncologist, assistant professor, clinical medicine, the University of Illinois

Samantha A. Armstrong, MD; Karine Tawagi, MD

Rare Cancers

Kristen N. Ganjoo, MD, sarcoma specialist, medical oncologist, Stanford Health Care; professor, medicine, Stanford Medicine

Andrew J. Wagner, MD, PhD, medical director, Ambulatory Oncology, senior physician, Dana-Faber Cancer Institute; associate professor, medicine, Harvard Medical School

Nader Sanai, MD

Michael C. Haffner, MD, PhD

Giuseppe Giaccone, MD, PhD; Yongfeng He, PhD

Conference Perspectives

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS

Peter Schmid, MD, PhD, FRCP, chair, Cancer Medicine, professor, cancer medicine, centre lead, the Centre of Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University; clinical director, Barts Breast Cancer Centre, St Bartholomew’s Hospital

Debu Tripathy, MD, professor, chairman, the Department of Breast Medical Oncology, the Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Elias Jabbour, MD

Hiba Khan, MD, MPH; Natasha Kwendakwema, MD

Nicholas James Short, MD

Oncology Expert Insights

Nam Bui, MD, sarcoma specialist, clinical assistant professor, medicine, Stanford Cancer Institute; Ciara Kelly, MBBCh, BAO, interim clinical director, Sarcoma Oncology Service, Memorial Sloan Kettering Cancer Center

Giuseppe Curigliano, MD, PhD, director, Early Drug Development Division, co-chair, Experimental Therapeutics Program, European Institute of Oncology

Robert Z. Orlowski, MD, PhD, Florence Maude Thomas Cancer Research Professorship, Department of Lymphoma/Myeloma, director, Section of Myeloma, professor, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Martin F. Dietrich, MD, PhD, medical oncologist, Cancer Care Centers of Brevard, The US Oncology Network, assistant professor, internal medicine, the University of Central Florida College of Medicine; Michelle Shiller, DO, cancer liaison physician, medical director, Genetics, assistant medical director, Baylor Scott & White Health in Dallas, medical director, Genomics and Molecular Pathology Services, PathGroup

Mark Agulnik, MD, professor, clinical medicine, vice chair, faculty development, Department of Medicine, section chief, Sarcomas & Melanoma, Keck School of Medicine, the University of Southern California

Karen L. Reckamp, MD, professor, medicine, medical oncology director, Lung Institute, director, Division of Medical Oncology, associate director, Clinical Research, Cedars-Sinai Medical Center

Talking Tumors

Disparities

Mariam F. Eskander, MD, MPH

Ana Velazquez Manana, MD

Faith Mutale, DNP, CRNP

Nicholas Acuna, MPH

State of the Science Summits

Fellowship

Sam Brondfield, MD, MA

Kevin Raskin, MD

Aakash P. Desai, MD, MBBS, MPH

Erin Crane, MD, MPH

Blood Club

Matthew Lunning, DO, FACP, associate professor, Division of Oncology & Hematology, associate vice chair, research, Department of Internal Medicine, assistant vice chancellor, clinical research, University of Nebraska Medical Center; Sarah Rutherford, MD, assistant professor, medicine, Division of Hematology/Oncology, Weill Cornell Medicine

Matthew Lunning, DO, FACP, associate professor, the Division of Oncology & Hematology, associate vice chair, research, the Department of Internal Medicine, assistant vice chancellor, clinical research, the University of Nebraska Medical Center

Matthew Lunning, DO, FACP

Matthew Lunning, DO, FACP

Matthew Lunning, DO, FACP

Matthew Lunning, DO, FACP

Roundtable Discussions

John H. Strickler, MD, associate professor, medicine, member, the Duke Cancer Institute; Michael Leung, PharmD, BCOP, clinical pharmacy specialist, Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center; Arvind N. Dasari, MD, MS, associate professor, the Department of GI Medical Oncology, the Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center; Margot O’Neill, PA-C, MHS, physician assistant, oncology, the Duke Cancer Institute

Blessy Mathew Jacob, MD; Ana Van Der Wall, MD; Vance M. Wright-Browne, MD

Lipika Goyal, MD; Katie Kelley, MD; Caroline Kulhman, NP; Chaundra Bishop

Melinda Butsch Kovacic, MPH, PhD; Elizabeth Shaughnessy, MD, PhD; Sandra L. Starnes, MD; Susan E. Waltz, PhD

USC Norris Comprehensive Cancer Center, UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center, Fox Chase Cancer Center, the University of Chicago Comprehensive Cancer Center

Jorge M. Mercado, MD; Stephen Kovacs, DO

Women In Oncology

Stephanie L. Graff, MD, director, Breast Oncology, Lifespan Cancer Institute, associate professor, medicine, Brown University; Reshma L. Mahtani, DO, medical oncologist, Miami Cancer Institute, chief, Breast Medical Oncology, Baptist Health’s Wellness and Medical Complex; Kelly E. McCann, MD, PhD, breast medical oncologist, assistant clinical professor, medicine, the University of California, Los Angeles Health David Geffen School of Medicine; Hope S. Rugo, MD, Winterhof Family Endowed Professor in Breast Cancer, the University of California San Francisco (UCSF), professor, medicine, Division of Hematology and Oncology, director, Breast Oncology, director, Clinical Trials Education, director, Cancer Infusion Services, the UCSF Helen Diller Family Comprehensive Cancer Center

Latest Conference Coverage

Enhanced Clinical Education and Simplified Guidelines Needed to Address Germline Testing Gaps in Breast Cancer

Research Propels Additional Options into the Advanced HER2+ Breast Cancer Armamentarium

Research With ctDNA Continues to Pave the Way Toward Optimal Breast Cancer Management

De-Escalation Strategies, Biomarkers Could Refine Treatment Algorithm for Early-Stage HER2+ Breast Cancer

View More Latest Conference Coverage

Editorial Board

CancerNetwork.com

OncNursingNews.com

TargetedOnc.com

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.